Transparent cover dressing application system and inclusion of label strip

Information

  • Patent Grant
  • 11213432
  • Patent Number
    11,213,432
  • Date Filed
    Thursday, March 13, 2014
    10 years ago
  • Date Issued
    Tuesday, January 4, 2022
    2 years ago
Abstract
A dressing having a multilayer assembly in which dressing includes a polyurethane dressing layer that is adhesively secured over a wound or other location on a user's skin. Label strips that can be incorporated into the dressing. The label strips can include text, indicia, logos, or other markings which are applied to the strip prior to or after application of the dressing.
Description
FIELD

The present subject matter relates to dressings made from films which are typically oxygen permeable, and have high moisture vapor permeability but which are impermeable to liquid water and bacteria. The dressings include a label strip that can include text, indicia, logos, or other markings. The subject matter also relates to methods of producing such dressings and similar products.


BACKGROUND

Wound dressings made with composite layers of film and adhesive which have high moisture vapor transmission rates are well known in the art. These dressings are used in many applications and are beneficial in that they are impervious to bacteria and liquid water but yet allow oxygen to penetrate the dressing from the ambient atmosphere and allow moisture from the skin of the patient to escape from beneath the dressing.


In order to obtain the desired moisture vapor transmission rate, the dressings are made from extremely thin films of polyurethane or of other polymeric materials which have the desired moisture vapor transmission properties. These films are extremely thin, typically less than 10 mils, and are very flexible, limp, and flimsy because of their thinness. These characteristics allow the dressing to be applied to the varying contours of the human body but also present difficulties in the application of the dressing to a patient. The dressings are typically provided with a release sheet covering the adhesive surface of the dressing. The release sheet is removed from the dressing when the dressing is applied to the patient. The thinness of the film and its flexibility allows the film to turn over onto itself during attempts to apply the film dressing to a patient. The film is similar in this property to polyvinylidene chloride film household wrap. When a portion of the adhesive surface of the film touches other portions of the adhesive surface, the film dressing sticks to itself and makes it extremely difficult to separate the adhered portions and then apply to the patient.


In order to overcome this problem, film dressings of this type have been provided with adhesive-free tabs at opposite ends of the film. In some products there is a reinforcing member at the tab ends to provide a grasping or holding surface to be used to apply the dressings to a patient.


Prior to or after application of a dressing or other adhesive thin film article to a patient, it may in certain applications be necessary to mark or otherwise apply text or information to the dressing. For example, for certain dressings, date information associated with the article may be included. In other instances, it may be desirable to include patient information or treatment information directly on the dressing or article. Although a medical practitioner could in certain instances, write or otherwise apply markings along an outer face of the dressing that practice may be undesirable. The outer face of the polyurethane film or other polymeric material may be difficult to write upon. Other parameters may detrimentally impact ability to write or apply markings on the dressing.


Accordingly, a need exits for a dressing or thin film article which may readily receive text or other markings or indicia.


SUMMARY

The difficulties and drawbacks associated with previously known dressings are addressed in the present articles and related methods.


In one aspect, the present subject matter provides a dressing comprising a dressing film defining an inner face and an oppositely directed outer face. The dressing also comprises a support film disposed on at least a portion of the outer face of the dressing. The dressing additionally comprises an adhesive disposed on at least a portion of the inner face of the dressing film. And, the dressing also comprises a label strip adhered to the outer face of the dressing film. The label strip has an outer face adapted to receive printing, marking, or other indicia.


As will be realized, the subject matter described herein is capable of other and different embodiments and its several details are capable of modifications in various respects, all without departing from the claimed subject matter. Accordingly, the drawings and description are to be regarded as illustrative and not restrictive.





BRIEF DESCRIPTION OF THE DRAWINGS


FIG. 1 is a perspective, schematic exploded assembly view of a dressing having a label strip in accordance with the present subject matter.



FIG. 2 is a schematic cross section of an end region of the dressing in FIG. 1, illustrating the label strip in greater detail.



FIG. 3 is a perspective, schematic view of another dressing having a label strip in accordance with the present subject matter.





DETAILED DESCRIPTION OF THE EMBODIMENTS

The present subject matter provides dressings which include one or more label strips. The label strip can include text, indicia, logos, or other markings. The label strip is incorporated into a transparent cover dressing such as a window dressing, or any dressing using a thin polymeric film (such as for example polyurethane) having an adhesive on a face of the film, for contacting skin. In certain embodiments of the present subject matter, the label strip is attached to an outer face of the transparent film. Attachment can be accomplished by a variety of techniques, however, attachment is typically achieved by adhesive. After application of the dressing to skin, the label remains attached to the outer face of the transparent film. Prior to (or after) application, writing or other operations can be performed to provide text or information on the label strip, which will remain with the dressing even after application.


The dressings generally comprise (i) an outer support film, (ii) one or more handling tabs attached to the support film, (iii) a thin dressing film, (iv) one or more adhesives on a face of the dressing film, (v) a liner covering the one or more adhesives prior to use or application of the dressing, and (vi) one or more label strips incorporated in the dressing and typically disposed on an outer face of the dressing film.


Details as to each of the components of the dressings are as follows.


Support Film

Transparent or translucent film materials are particularly intended as supporting films. However, opaque or non-transparent paper or film materials can be used alternatively. Useful as supporting films are particularly those films that are manufactured from polyester, polyethylene, polypropylene, polyvinylchloride, polystyrene, polyamide, polycarbonate, cellulose ester, ethylene vinyl acetate, polyvinyl acetate, polyvinyl alcohol and/or combinations thereof. Particularly preferred are supporting films from polyester or polyethylene or polypropylene. The present subject matter also includes the use of paper or paper-based materials for the support component. Combinations of polymeric and paper materials can also be used. It has been proven to be particularly preferable when the thickness of the supporting films are adjusted to a thickness of about 15 to about 80 μm, particularly from about 20 to about 60 μm and especially from about 20 to about 40 μm.


Handling Tabs

One or more optional handling tab(s) may be incorporated into the dressing and is provided either partially or entirely along an edge of the dressing and/or the support film. Handling tabs can be provided on the support film, the release liner, or both. When provided on the support film, the handling tab can be in the form of an integral extension or projection of the support film. In certain versions, the handling tab is arranged near the center of a side edge of the dressing. However, the handling tab can have various other configurations and arrangements. Also, the location can be as desired and more than one handling tab can be provided.


Dressing Film

The dressing film is preferably made of a thin, flexible, conformable, resilient, supple, limp or flimsy material that can flex or bend to conform to irregular surfaces or contours, such as those of anatomical body parts. Preferably, dressing film is sufficiently resilient to stretch or flex in response to movement or flexing of the dressing support film and to conform to the dressing support film when the dressing support film returns to an unflexed condition. The dressing film is preferably transparent or substantially transparent to permit visualization through the dressing film and/or of the support film. Or, the dressing film can be opaque. The dressing film can be air permeable to allow oxygen to penetrate the dressing as well as moisture vapor permeable to allow moisture from the skin surface to escape through the dressing, and the dressing film can be liquid, air and bacteria impermeable. Non limiting examples of materials suitable for the dressing film include polymeric materials, such as polyurethane, copolyester, elastomeric polyester, polyethylene, blends of polyurethane and polyester, chlorinated polyethylene, styrene/butadiene block copolymers and polyvinyl chloride, formed into continuous films or sheets by casting, extrusion or other processes. The dressing film can have various sizes and configurations dependent on the surfaces to which the dressing is to be applied. The dressing film may have a square or rectangular peripheral configuration with rounded or radiused corners. The present subject matter includes nearly any shape for the dressing film. The dressing film preferably has a minimal thickness, typically in the range of 0.0005 inch to 0.004 inch, preferably about 0.0015 inch, with conformability of the dressing increasing with decreasing thickness of the dressing film.


Adhesives

Adhesive is provided on a skin contacting side or face of the dressing film to cover at least the entire area circumscribed by the final dressing portion and, preferably, for ease of manufacturing adhesive covers the entire area of face of the dressing film including a peripheral backing portion. Adhesive can be provided on a face of the dressing film in many various ways including solvent spreading, spraying, coating and extrusion, for example, and the adhesive can be applied directly to the dressing film or indirectly via a carrier sheet. The adhesive utilized is preferably a pressure sensitive, skin contact adhesive that is preferably hypo-allergenic and non-irritating to skin. Representative non-limiting examples of materials suitable for the adhesive include acrylate copolymers, such as copolymers of 2-ethylhexylacrylate and vinyl acetate with or without a cross-linking agent, water based adhesives and hot melt adhesives, for example. If desired, various medicaments and/or antimicrobial agents can be included in the adhesive to promote healing and inhibit infection. The adhesive is preferably applied on a face of the dressing film in a thin layer, such as on the order of 0.001 inch to 0.010 inch in thickness or greater (according to the desired application), sufficient to obtain adequate skin adhesion without impairing the air and moisture vapor transmission characteristics of the dressing. Preferably, the adhesive is an acrylic adhesive.


Release Liner

Various materials can be utilized for the release liner including conventional smooth surface paper materials, polyester films and polyolefin films of the type typically utilized as release liners, such as, for example, kraft paper, polyethylene, polypropylene, polyester and composites thereof. In certain applications, the release liner is sufficiently thick, i.e., on the order of 0.004 inch to 0.0075 inch in thickness or higher, to rigidify a backing sheet prior to use. The release liner is preferably sufficiently rigid and/or thick to typically maintain a flat configuration. However, the release liner can have some flexibility to bend, flex or deform in response to external pressure. Depending on the material utilized for the release liner, the surface can be coated with a release agent, such as fluorochemicals or silicone, for example, to facilitate release of the liner portion from the adhesive of the final dressing. It will be appreciated that the material utilized for the release liner, with or without a release agent, can be varied to achieve a desired bond or tenacity of adhesion between the release liner and the adhesive and that the bond or tenacity of adhesion can be selected such that manual removal or peeling away of the liner portion from the backing sheet can be accomplished with a gentle pressure or pulling force and without damage to or impairment of the dressing.


The liner can be a single panel liner or include multiple components or panels to form a liner assembly.


Label Strips

A wide range of materials can be used for the label strips that are associated with the dressings. In certain embodiments, the label strips are formed from paper or paper based materials. However, the present subject matter includes forming the label strips from polymeric materials. It is also contemplated that the label strips can be formed from combinations of paper and polymeric materials and be in the form of composite materials. The present subject matter also includes forming the label strips with one or more regions or layers of paper material(s) and one or more regions or layers of polymeric materials. Furthermore, one or both faces of the label strip and particularly a print-receiving face can be coated with a print-receptive topcoat to promote ink adherence or ink “wet-out.” Moreover, one or both faces of the label strip could be subjected to a surface treatment operation such as corona treatment or plasma treatment.


The label strip can also be coated with a release coating so that an adhesive coated portion of the handling tab can extend over the label strip. This configuration provides extra support to the dressing on application (and before removal of the support layer and associated handling tab). In this case the release coating is chosen to prevent permanent or strong adhesion of the handling tab and to provide significant “wet out” for the ink to allow writing/printing on the tab.


The one or more label strip(s) are typically disposed on an outer face of the dressing film. The label strip(s) can be secured to the dressing film such as by adhesive. The label strip(s) in certain versions of the dressings, are provided immediately alongside a recessed side edge of a support film. In particular versions of the dressings, the label strip(s) are positioned under the handling tab(s). And in specific versions of the present subject matter, the label strip(s) are disposed between a handling tab the dressing film, and also immediately alongside an edge of a support film. However, it will be understood that the present subject matter includes a wide range of arrangements, configurations, and variations of the dressings described herein.



FIGS. 1 and 2 illustrate a dressing 10 in accordance with the present subject matter. The dressing 10 comprises a handling tab 20, a support film 30, a label strip 40, a dressing film 50, and a release liner 60. The handling tab 20 defines an outer face 22 and an oppositely directed inner face 24. The support film 30 defines an outer face 32 and an oppositely directed inner face 34. In the particular version of dressing 10 depicted in FIG. 1, the handling tab 20 is adhesively attached to a peripheral edge region of the outer face 32 of the support film 30. The label strip 40 also defines an outer face 42 and an oppositely directed inner face 44. The outer face 42 receives text, markings, and/or indicia as described herein. The label strip 40 is disposed on an outer face 52 of the dressing film 50. In the particular version of dressing 10 shown, the label strip 40 is oriented parallel to and immediately alongside a recessed edge of the support film 30. A thin layer or coating of adhesive (not shown) resides on an inner face 54 of the dressing film 50. The release liner 60 covers the adhesive, and specifically a release coated face 62 of the liner 60 contacts the adhesive layer on the inner face 52 of the dressing film 50. The release liner 60 also defines an outer face 64 which is opposite the release coated face 62. In the particular version of the dressing 10 depicted in FIG. 1, a side edge or peripheral edge portion of the liner 60 extends outward beyond a corresponding edge of the dressing film 50, and in certain versions also beyond a corresponding edge of the label strip 40. The release liner edge may or may not extend beyond the handling tab 20. In the version of dressing 10 depicted in FIG. 1, the handling tab 20 extends further beyond the corresponding edge of the liner 60.



FIG. 2 is a schematic cross sectional view of an edge portion of the dressing 10 depicted in FIG. 1. FIG. 2 illustrates a particular version of the dressing 10 in which the handling tab 10 extends beyond a corresponding edge region of the liner 60, and the liner 60 extends beyond corresponding edge regions of the label strip 40 and the dressing film 50.



FIG. 3 is a perspective view of another dressing 100 in accordance with the present subject matter. In this version, the dressing 100 defines an interior slot or access region 105. This configuration is typical for certain dressings used to cover body apertures for IV tubes, typically referred to as peripheral IV (PIV) dressings. The dressing 100 includes a dressing film 150 and a label strip 140 extending along an edge of the dressing. FIG. 3 illustrates the dressing 100 after application such as to a patient (not shown), and removal of a support film (not shown) that would otherwise cover the dressing film 150, and removal of handling tabs (not shown) that were attached to the support film.


Many other benefits will no doubt become apparent from future application and development of this technology. For example, the label strip can add additional bulk to the limp flimsy film to facilitate removal of the dressing from the skin after use. Due to the low caliper of the dressings it is typically very difficult to get a starting point for removal. The extra thickness and stiffness at the label strip position can significantly assist or promote removal efforts.


All patents, published applications, and articles noted herein are hereby incorporated by reference in their entirety.


As described hereinabove, the present subject matter solves many problems associated with previous strategies, systems and/or devices. However, it will be appreciated that various changes in the details, materials and arrangements of components, which have been herein described and illustrated in order to explain the nature of the present subject matter, may be made by those skilled in the art without departing from the principle and scope of the claimed subject matter, as expressed in the appended claims.

Claims
  • 1. A dressing comprising: a dressing film defining an inner face and an oppositely directed outer face;a support film disposed on at least a portion of the outer face of the dressing;an adhesive disposed on at least a portion of the inner face of the dressing film; anda label strip adhered to the outer face of the dressing film, the label strip having an outer face adapted to receive printing, marking, or other indicia; andat least one handling tab disposed on and attached to the support film;wherein an the label strip is disposed immediately alongside an recessed edge of the support film; andwherein the label strip remains attached to the dressing film after application of the dressing.
  • 2. The dressing of claim 1 further comprising: a release liner covering the adhesive.
  • 3. The dressing of claim 2 wherein an edge of the release liner extends beyond a corresponding edge of the dressing film.
  • 4. The dressing of claim 2 wherein an edge of the release liner extends beyond a corresponding edge of the label strip.
  • 5. The dressing of claim 1 wherein the label strip includes paper.
  • 6. The dressing of claim 1 wherein the dressing film includes polyurethane.
  • 7. The dressing of claim 1 wherein the support film includes a material selected from the group consisting of paper, polymeric materials, and combinations thereof.
  • 8. The dressing of claim 1 wherein an edge of the handling tab extends beyond a corresponding edge of the support film.
  • 9. The dressing of claim 1 wherein an edge of the handling tab extends beyond a corresponding edge of the label strip.
  • 10. The dressing of claim 1 wherein an edge of the handling tab extends beyond a corresponding edge of the dressing film.
  • 11. The dressing of claim 1 wherein an edge of the handling tab extends beyond a corresponding edge of the release liner.
CROSS REFERENCES TO RELATED APPLICATIONS

The present application is a 371 of International Patent Application No. PCT/US2014/025549 which was published in English on Sep. 25, 2014 and claims the benefit of U.S. Provisional Application No. 61/787,908 filed Mar. 15, 2013, both of which are incorporated herein by reference in their entireties.

PCT Information
Filing Document Filing Date Country Kind
PCT/US2014/025549 3/13/2014 WO 00
Publishing Document Publishing Date Country Kind
WO2014/151355 9/25/2014 WO A
US Referenced Citations (92)
Number Name Date Kind
2736721 Dexter Feb 1956 A
4199567 Rankin Apr 1980 A
4310509 Berglund et al. Jan 1982 A
4434181 Marks, Sr. et al. Feb 1984 A
4460369 Seymour Jul 1984 A
4600001 Gilman Jul 1986 A
4753232 Ward Jun 1988 A
4941882 Ward et al. Jul 1990 A
4990144 Blott Feb 1991 A
5018516 Gilman May 1991 A
5069907 Mixon et al. Dec 1991 A
5214119 Leir et al. May 1993 A
5270358 Asmus Dec 1993 A
5322695 Shah et al. Jun 1994 A
5340581 Tseng et al. Aug 1994 A
5382451 Johnson et al. Jan 1995 A
5389376 Duan et al. Feb 1995 A
5441741 Cheong Aug 1995 A
5614310 Delgado et al. Mar 1997 A
5686096 Khan et al. Nov 1997 A
5702721 Horstmann et al. Dec 1997 A
5717005 Richardson Feb 1998 A
5763412 Khan et al. Jun 1998 A
5908693 Delgado et al. Jun 1999 A
6043406 Sessions Mar 2000 A
6228354 Jeng May 2001 B1
6455086 Trinh et al. Sep 2002 B1
6458341 Rozzi et al. Oct 2002 B1
6495158 Buseman et al. Dec 2002 B1
6518359 Clemens et al. Feb 2003 B1
6565873 Shefer et al. May 2003 B1
6589562 Shefer et al. Jul 2003 B1
6599525 Scamilla Aledo et al. Jul 2003 B2
6642304 Hansen et al. Nov 2003 B1
6733745 Rozzi et al. May 2004 B2
6742522 Baker Jun 2004 B1
6844306 Werle et al. Jan 2005 B2
6893655 Flanigan et al. May 2005 B2
7160976 Luhmann et al. Jan 2007 B2
7674473 Falder et al. Mar 2010 B2
7683216 Dubois et al. Mar 2010 B2
7704523 Serafica et al. Apr 2010 B2
7824122 Flores et al. Nov 2010 B2
8623935 Hobbs et al. Jan 2014 B2
8969649 Leibowitz et al. Mar 2015 B2
9101134 Huang et al. Aug 2015 B2
9278155 Asmus et al. Mar 2016 B2
9346981 Wibaux et al. May 2016 B2
9592161 Rule et al. Mar 2017 B2
9764059 Wibaux et al. Sep 2017 B2
9801902 Smith et al. Oct 2017 B2
10329384 Hansen et al. Jun 2019 B2
10456498 Wibaux Oct 2019 B2
20020018814 Werle et al. Feb 2002 A1
20020072480 Werle et al. Jun 2002 A1
20030077316 Nichols et al. Apr 2003 A1
20030212005 Petito Nov 2003 A1
20040009202 Woller Jan 2004 A1
20040063792 Khera et al. Apr 2004 A1
20040109869 Glenn et al. Jun 2004 A1
20040170794 Verhaert Sep 2004 A1
20040241214 Kirkwood et al. Dec 2004 A1
20050049365 Cleary et al. Mar 2005 A1
20050118246 Wong et al. Jun 2005 A1
20050244346 Nakao et al. Nov 2005 A1
20050249791 Hobbs et al. Nov 2005 A1
20070116729 Palepu May 2007 A1
20070259029 McEntire et al. Nov 2007 A1
20080220045 Shalaby et al. Sep 2008 A1
20080233177 Meconi Sep 2008 A1
20090130157 Ylitalo et al. May 2009 A1
20100022654 Asmus et al. Jan 2010 A1
20100029779 Street et al. Feb 2010 A1
20100081672 Wan et al. Apr 2010 A1
20100303878 Slager et al. Dec 2010 A1
20100322996 Wibaux et al. Dec 2010 A1
20110067799 Mussig et al. Mar 2011 A1
20120078155 Bowman et al. Mar 2012 A1
20120245538 Horstmann et al. Sep 2012 A1
20120328682 Bardwell et al. Dec 2012 A1
20130072566 Asmus et al. Mar 2013 A1
20130239977 McGuire, Jr. Sep 2013 A1
20130243841 Kommareddy et al. Sep 2013 A1
20130303656 Wibaux et al. Nov 2013 A1
20140322299 Wibaux Oct 2014 A1
20150056291 Wibaux et al. Feb 2015 A1
20150367021 Wibaux Dec 2015 A1
20160000609 Van Holten et al. Jan 2016 A1
20160228600 Wibaux et al. Aug 2016 A1
20170007464 Liu et al. Jan 2017 A1
20170095431 Andrews et al. Apr 2017 A1
20200016291 Wibaux Jan 2020 A1
Foreign Referenced Citations (52)
Number Date Country
1985043241 Dec 1985 AU
1207228 Jul 1986 CA
2333009 Dec 1999 CA
1522687 Aug 2004 CN
1961666 May 2007 CN
101653431 Feb 2010 CN
0066899 Dec 1982 EP
0404558 Dec 1990 EP
0328421 Apr 1993 EP
0361722 Dec 1993 EP
1139981 Apr 2002 EP
1203531 Nov 2003 EP
1784232 May 2007 EP
3280769 Feb 2018 EP
3368086 Sep 2018 EP
2968014 Apr 2019 EP
2274586 Aug 1994 GB
1990-147063 Jun 1990 JP
6-508287 Sep 1994 JP
6-509955 Nov 1994 JP
2825549 Nov 1998 JP
2002179513 Jun 2002 JP
2002-272831 Sep 2002 JP
2002-332228 Nov 2002 JP
2003534310 Nov 2003 JP
2004010545 Jan 2004 JP
2007502319 Feb 2007 JP
2007-526348 Sep 2007 JP
2007-536261 Dec 2007 JP
2014510038 Apr 2014 JP
1990013780 Nov 1990 WO
WO9300118 Jan 1993 WO
WO1993002717 Feb 1993 WO
WO9303649 Mar 1993 WO
WO1999000025 Jan 1999 WO
1999023150 May 1999 WO
WO992470 Dec 1999 WO
WO2000036353 Jun 2000 WO
WO2000061692 Oct 2000 WO
2003103618 Dec 2003 WO
2004080499 Sep 2004 WO
2009064291 May 2009 WO
WO2010080936 Jul 2010 WO
2011009083 Jan 2011 WO
WO2011088072 Jul 2011 WO
WO2012100244 Jul 2012 WO
2012158483 Mar 2013 WO
WO2013074628 May 2013 WO
2013090191 Jun 2013 WO
2014124232 Aug 2014 WO
2015188031 Dec 2015 WO
2015187632 Dec 2015 WO
Non-Patent Literature Citations (30)
Entry
Giunchedi, et al. “Formulation and in vivo evaluation of chlorhexidine buccal tablets prepared using drug-loaded chitosan microspheres,” European Journal of Pharmaceutics and Biopharmaceutics, Elsevier Science Publishers B.V., Amsterdam, NL, vol. 53, No. 2, Mar. 1, 2002, pp. 233-239, XP004342819, ISSN: 0939-6411, DOI: 10.1016/S0939-6411(01)00237-5 Section 2.2 Preparation by spray-drying; table 2.
International Search Report and Written Opinion issued in corresponding IA No. PCT/US2012/022162 dated Aug. 10, 2012.
Avery Dennison Medical Solutions Demonstrates the Efficacy of its new Chlorhexidine Gluconate Adhesive Delivery System, Avery Dennison Medical Solutions, Sep. 13, 2011, 1-2.
Boddupalli, et al., Mucoadhesive drug delivery system: An overview, Jounal of Advanced Pharmaceutical Technology & Research, vol. 1, 2010, 381-387.
Ceballos, et al., Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets, II Farmaco, Jan. 15, 2005, 913-918, vol. 60, No. 11-12.
Cui, et al., Bilayer Films for Mucosal (Genetic) Immunization via the Buccal Route in Rabbits, Pharmaceutical Research, Jul. 2002, 947-953, vol. 19, No. 7.
Eudragit, acrylic polymers for solid oral dosage forms, Jan. 1, 2008, 1-11.
International Search Report and Written Opinion of the International Searching Authority, or the Declaration issued in corresponding IA No. PCT/US14/15263 dated Sep. 19, 2014.
International Search Report and Written Opinion of the International Searching Authority, or the Declaration issued in corresponding IA No. PCT/US2015/033689 dated Sep. 8, 2015.
International Search Report and Written Opinion of the International Searching Authority, or the Declaration issued in corresponding IA No. PCT/US2012/065014 dated Feb. 15, 2013.
Invitation to Pay Additional Fees issued in corresponding IA No. PCT/US2012/022162 dated Apr. 12, 2012.
Maruzen, “New Experimental Chemistry Course 1 Basic Operation I”, Sep. 20, 1975, 459-463.
Yue, et al., A novel polymeric chlorhexidine delivery device for the treatment of periodontal disease, Biomaterials, vol. 25, 2004, pp. 3743-3750.
International Search Report and Written Opinion of the International Searching Authority, or the Declaration issued in corresponding IA No. PCT/US2015/034336 dated Mar. 23, 2016.
International Search Report and Written Opinion issued in corresponding IA No. PCT/US2014/025549 dated Jul. 25, 2014.
International Preliminary Reporton Patentability dated Sep. 24, 2015 issued in corresponding IA No. PCT/US2014/025549 filed Mar. 13, 2014.
International Preliminary Report on Patentability dated Jul. 23, 2013 issued in corresponding IA No. PCT/US2012/022162 filed Jan. 23, 2012.
International Search Report and Written Opinion dated Jan. 21, 2013 issued in corresponding IA No. PCT/US2012/037429 filed May 11, 2012.
International Preliminary Report on Patentability dated Nov. 19, 2013 issued in corresponding IA No. PCT/US2012/037429 filed May 11, 2012.
Pei, et al. “Plant Fiber Chemistry”, pp. 244-246, China Light Industry Press, Jul. 2012.
International Preliminary Report on Patentability dated May 20, 2014 issued in corresponding IA No. PCT/US2012/065014 filed Nov. 14, 2012.
Sateesh Kandavilli: “Polymers in Transdermal Drug Delivery Systems,” Pharmaceutical Technology, May 31, 2002, XP055101101, Retrieved from the internet: http://www.pharamtech.com/pharmtech/data/articiestandard/pharmtech/192002/18600/article.pdf [retrieved on Feb. 10, 2014].
Luo, et al., A Complete Collection of Pharmaceutical Excipients, Sichuan university of science and technology press, Jan. 31, 2006, 53-56.
International Preliminary Report on Patentability dated Dec. 6, 2016 issued in corresponding IA No. PCT/US2015/034336 filed Jun. 5, 2015.
He et al., General Practitioner's Guidelines for Medication Use, Beijing Science and Technology Press, Nov. 30, 2010, 1205.
Yao, Application Directory of Pharmaceutical Excipients, China Medical Science and Technology Press, Aug. 31, 2011, 1342-1347.
International Preliminary Report on Patentability dated Jul. 6, 2015 issued in corresponding IA. No. PCT/US2014/015263 filed Feb. 7, 2014.
Invitation to Pay Additional Fees dated May 22, 2014 issued in corresponding IA No. PCT/US2014/015263 filed Feb. 7, 2014.
International Preliminary Report on Patentability dated Dec. 15, 2016 issued in corresponding IA No. PCT/US2015/033689 filed Jun. 2, 2015.
Polysciences, Poly(acrylic acid), 25% soln, in water [PAA ˜50,000], Retrieved Aug. 14, 2021 (Year 2021).
Related Publications (1)
Number Date Country
20160030248 A1 Feb 2016 US
Provisional Applications (1)
Number Date Country
61787908 Mar 2013 US